Victoria is the premier location for medical research and clinical trials in Australia and recognised globally as a health and medical research centre of excellence.
The Victorian Government has committed $1.3 billion to medical research since 2014. That investment has helped Victoria to emerge as a world leader in cutting-edge health and medical research – driving growth in the sector, creating jobs and supporting incredible breakthroughs in treatment and care.
Find out more about our key initiatives below.
Australian Institute for Infectious Disease
The Victorian Government is committed to the development of a new Australian Institute of Infectious Disease in Victoria to lead the fight against future pandemics.
Building on $155 million in funding announced in 2020, the Victorian Government will deliver up to an additional $245 million to get the project off the ground and build the Institute in the heart of the Parkville biomedical precinct.
The $650 million project will also be supported with $250 million from the Foundation Partners – the University of Melbourne, the Doherty Institute for Infection and Immunity and the Burnet Institute.
The COVID-19 pandemic has highlighted the importance of getting ahead of outbreaks. This Institute is designed to deliver the necessary infrastructure and capacity that researchers need to detect, analyse, manage and develop treatments for infectious diseases.
The Institute will be the largest centre of expertise in the Southern Hemisphere region and will supercharge the ongoing efforts of the world-leading researchers at Victoria’s universities and medical research institutes. It will also accelerate research into the prevention of future pandemics and rapidly developing treatments.
It will be the new home of the Burnet Institute and, being located next to the Doherty Institute, will also enable the Doherty to expand its research operations.
In addition, it will bring together experts from the Walter and Eliza Hall Institute for Medical Research, the Murdoch Children’s Research Institute and Melbourne-headquartered global biotechnology company CSL, to ensure Victoria and Australia are prepared for future challenges.
The Institute will include next-generation laboratories and high-containment facilities that will help researchers improve our understanding of infectious diseases, and a robotic biobank facility will ensure international best practice for specimen storage in large-scale clinical trials.
This project is expected to create approximately 350 jobs through the design and establishment phase. These jobs include roles in architecture, engineering, planning, surveying, construction, information technology, communications and consulting services to design and fit-out.
The Institute also has the potential to support up to 5,000 jobs, including approximately 850 jobs at the institute itself, as well as creating jobs within the new research ecosystem including startups and commercial tenants.
Visit the AIID website to learn more.
COVID-19 research projects
Since the start of the pandemic, the Victorian Government has committed over $31 million in funding to COVID-19 research projects across the state.
This investment is supporting our world-class research community to better understand transmission, immunity and the long-term health impacts of COVID-19. Learn more
The Victorian Government is committed to developing our mRNA capability to provide vaccine security, support local manufacturing and create a more robust defence against future pandemics.
By supporting supply chain, research and development, commercialisation and manufacturing investments, mRNA Victoria is leading the charge to establish a world-class mRNA and RNA industry right here in Victoria. Learn more
Page last updated: 15 December 2021